GitLab's latest release uses AI for more than just making code completion smarter, with customisable agents, a Knowledge Graph, and more.
Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback